Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Roxithromycin + ambroxol tablets in lower respiratory tract bacterial infection
CTR20171011Phase 4Completed
- Sponsor
- Roxin Pharmaceutical
- Start
- Sep 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of roxithromycin + ambroxol in acute bronchitis, chronic bronchitis (CB), sponsored by Roxin Pharmaceutical. Started Sep 2017; status: completed.
02
Drugs
roxithromycin + ambroxol
03
Conditions
acute bronchitischronic bronchitis (CB)
Beyond the preview
Go deeper on CTR20171011.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20171011.